🔴 Boston Scientific is trading 4.18% down amid broader positioning pressures

Boston Scientific is trading at $42.77, down -4.18%, amid reported steady selling and broader positioning pressures.

• No new company-specific announcement explaining the November 6 decline was identified.
• Recent earnings and guidance concerns, along with analyst downgrades, remain background risks; available reporting does not establish them as the direct cause of this session’s move.
• Healthcare-sector weakness may have contributed, while the broader market was mixed-to-positive, so the decline was not clearly index-wide.